Thus, our results demonstrated that selected subpopulation of EVs expressing PD-L1 or PD1 can be valuable tools for oncologists in choosing MM patients with a high probability of responding to immunotherapy with anti-PD1. The gene discussed is CD274; the disease is Miyoshi myopathy.